NYT: DePuy Hip Risk Assessment Inadequate
ASRHipSettlement.com News
January 31, 2013 – As the nation’s first trial alleging defective design among other causes of action against DePuy Orthopaedics regarding the recalled Articular Surface Replacement (ASR) artificial hip implant device moves forward in Los Angeles, some headlines are painting a bleak picture for the Johnson & Johnson subsidiary.
Today’s New York Times features a headline that points out J&J’s own internal review inadequacies when it set out to assess the device’s potential risks before it was used on more than 90,000 patients.
Our firm continues to monitor Kransky v DePuy et al because of the impact it may have on the more than 10,000 other lawsuits currently pending in courts across the country. As a bellwether case, it is likely to have meaningful bearing on future settlement talks.
To read why our firm feels so personally connected to this particular litigation and to learn about the structured settlement option potentially available to the plaintiffs, visit our dedicated website to learn more at . . .
Our firm will continue to monitor this case with great interest.
Posted: January 31, 2013 | by dan | Category: Articles, Blog, DePuy ASR Hip Recall, Structured Settlements
